Intuitive Surgical (NASDAQ:ISRG) Hits New 52-Week High at $433.47

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $433.47 and last traded at $433.07, with a volume of 70078 shares trading hands. The stock had previously closed at $430.00.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Piper Sandler lifted their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. BTIG Research lifted their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. The Goldman Sachs Group started coverage on Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective on the stock. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $403.67.

View Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Trading Up 0.7 %

The firm has a market capitalization of $153.62 billion, a PE ratio of 77.62, a price-to-earnings-growth ratio of 5.50 and a beta of 1.39. The business’s 50 day simple moving average is $393.56 and its two-hundred day simple moving average is $375.72.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction on Friday, April 26th. The shares were sold at an average price of $369.92, for a total value of $554,140.16. Following the completion of the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 1,498 shares of the stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the transaction, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,956 shares of company stock valued at $6,927,011. Company insiders own 0.80% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently made changes to their positions in ISRG. Baystate Wealth Management LLC raised its position in shares of Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. Creekmur Asset Management LLC raised its position in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $28,000. Finally, Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.